12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
週五盤後交易時段，12只醫療保健類股走勢
Gainers
獲勝者
- Intelligent Bio Solutions (NASDAQ:INBS) stock rose 8.6% to $2.14 during Friday's after-market session. The company's market cap stands at $4.9 million.
- MSP Recovery (NASDAQ:LIFW) shares increased by 6.68% to $0.23. The company's market cap stands at $76.1 million.
- Mesoblast (NASDAQ:MESO) stock increased by 5.0% to $4.2. The market value of their outstanding shares is at $683.4 million.
- Annexon (NASDAQ:ANNX) stock rose 4.98% to $3.37. The market value of their outstanding shares is at $178.8 million.
- Matinas BioPharma Hldgs (AMEX:MTNB) shares increased by 4.87% to $0.39. The market value of their outstanding shares is at $85.7 million.
- Renalytix (NASDAQ:RNLX) stock increased by 4.72% to $3.1. The market value of their outstanding shares is at $146.9 million.
- 智能生物解決方案 納斯達克股票代碼：INBS）股價在週五的盤後交易時段上漲8.6％，至2.14美元。該公司的市值爲490萬美元。
- MSP 恢復 納斯達克股票代碼：LIFW）股價上漲6.68％，至0.23美元。該公司的市值爲7,610萬美元。
- mesoblast 納斯達克股票代碼：MESO）股票上漲5.0％，至4.2美元。他們已發行股票的市值爲6.834億美元。
- Annexon 納斯達克股票代碼：ANNX）股價上漲4.98％，至3.37美元。他們已發行股票的市值爲1.788億美元。
- 馬蒂納斯生物製藥控股公司 (AMEX: MTNB) 的股價上漲了4.87％，至0.39美元。他們已發行股票的市值爲8,570萬美元。
- Renalytix 納斯達克股票代碼：RNLX）股票上漲4.72％，至3.1美元。他們已發行股票的市值爲1.469億美元。
Losers
失敗者
- OKYO Pharma (NASDAQ:OKYO) shares declined by 29.6% to $1.55 during Friday's after-market session. This security traded at a volume of 249.0K shares come close, making up 245.0% of its average volume over the last 100 days. The company's market cap stands at $39.5 million.
- Science 37 Hldgs (NASDAQ:SNCE) shares declined by 7.14% to $0.25. The market value of their outstanding shares is at $29.1 million.
- Impel Pharmaceuticals (NASDAQ:IMPL) stock fell 6.21% to $1.36. The market value of their outstanding shares is at $32.2 million.
- OptiNose (NASDAQ:OPTN) stock fell 5.99% to $1.1. The company's market cap stands at $123.1 million.
- eFFECTOR Therapeutics (NASDAQ:EFTR) shares decreased by 5.21% to $0.77. The company's market cap stands at $47.5 million.
- Navidea Biopharmaceutical (AMEX:NAVB) stock declined by 5.16% to $0.09. Navidea Biopharmaceutical's trading volume hit 2.9 million shares by close, accounting for 40.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $3.1 million. See Also:
- 東京製藥 納斯達克股票代碼：OKYO）股價在週五的盤後交易時段下跌29.6％，至1.55美元。該證券的交易量接近24.9萬股，佔其過去100天平均成交量的245.0％。該公司的市值爲3,950萬美元。
- 科學 37 控股公司 納斯達克股票代碼：SNCE）股價下跌7.14％，至0.25美元。他們已發行股票的市值爲2910萬美元。
- Impel 製藥 納斯達克股票代碼：IMPL）股價下跌6.21％，至1.36美元。他們已發行股票的市值爲3,220萬美元。
- optiNose 納斯達克股票代碼：OPTN）股價下跌5.99％，至1.1美元。該公司的市值爲1.231億美元。
- Effector 療法 納斯達克股票代碼：EFTR）股價下跌5.21％，至0.77美元。該公司的市值爲4,750萬美元。
- Navidea 生物製藥 (AMEX: NAVB) 股價下跌5.16％，至0.09美元。截至收盤，Navidea Biopharmaceutical的交易量達到290萬股，佔其過去100天平均交易量的40.5％。他們已發行股票的市值爲310萬美元。 另請參閱：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。